Recent

% | $
Quotes you view appear here for quick access.

Medivation, Inc. Message Board

  • biofutures biofutures Nov 2, 2012 1:35 PM Flag

    Tino just bought a huge block of MDVN...

    The coyote of the desert always likes to eat the heart of the young, where the blood drips down to children for breakfast, lunch and dinner, only the ribs will be broken in two.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You're a joke. Lol down 30% in 30 days & your still trying to convince them its a buy pathetic!

      Sentiment: Strong Sell

      • 2 Replies to dickeymellon
      • Down 30%? Better get yourself a new calculator.

      • Medivation is a bio-pharmaceutical company based in San Francisco, California. It focuses in producing drugs for the treatment of serious diseases. MDVN collaborates with Astellas for the development and marketing of its prostate cancer drug.

        Columbus increased its shares in Medivation by 134% in the third quarter. The company now comprises 1.22% of the asset manager's total holdings. CCI initiated its position during the first quarter, and then drastically increased it by 259% in the second quarter.

        Recent reports show that the sales of Medivation's prostate cancer drug Xtandi have just surpassed analysts' expectations. The company's marketer reported third quarter revenue of $14 million even when the drug hit the market only in the middle of September. Thus, the quarterly revenue growth (yoy) is 171.61%. The stocks year-to-date performance has improved by about 106%.

 
MDVN
60.95+3.16(+5.47%)Jun 29 4:00 PMEDT